Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Scoring system developed by UCSD- and UCSF-led research teams may be able to predict an individual's likelihood (and age-specific risk) of developing AD.
Molecular analysis of biological samples is typically outsourced to well-equipped (and cost-intensive) laboratories. However, there are times when sample diagnosis and DNA sequencing is needed quickly, needed in…
John Lehr, CEO of the Parkinson’s Foundation, shares insights into how advances in research, education, and advocacy for patients with Parkinson’s (and the disease itself) is performed and…
Perfusion decellularization has recently been used to remove genetic material in pig organs, allowing them to be seeded with human stem cells in the hopes of securing a…
